Background. Hepcidin secreted by hepatocytes is a key regulator of iron metabolism throughout the body. Hepcidin concentrations are increased in chronic kidney disease (CKD), contributing to abnormalities in iron metabolism. Levels of indoxyl sulfate (IS), a uremic toxin, are also elevated in CKD. However, the effect of IS accumulation on iron metabolism remains unclear. Methods. We used HepG2 cells to determine the mechanism by which IS regulates hepcidin concentrations. We also used a mouse model of adenine-induced CKD. The CKD mice were divided into two groups: one was treated using AST-120 and the other received no treatment. We examined control mice, CKD mice, CKD mice treated using AST-120 and mice treated with IS via drinking water. Results. In the in vitro experiments using HepG2 cells, IS increased hepcidin expression in a dose-dependent manner. Silencing of the aryl hydrocarbon receptor (AhR) inhibited IS-induced hepcidin expression. Furthermore, IS induced oxidative stress and antioxidant drugs diminished IS-induced hepcidin expression. Adenine-induced CKD mice demonstrated an increase in hepcidin concentrations; this increase was reduced by AST-120, an oral adsorbent of the uremic toxin. CKD mice showed renal anemia, decreased plasma iron concentration, increased plasma ferritin and increased iron content in the spleen. Ferroportin was decreased in the duodenum and increased in the spleen. These changes were ameliorated by AST-120 treatment. Mice treated by direct IS administration showed hepatic hepcidin upregulation.
I N T R O D U C T I O N
As the incidence of chronic kidney disease (CKD) has increased worldwide, morbidity and mortality in the general population have worsened [1, 2] . Patients with CKD often have renal anemia and they are generally treated using both iron supplementation and an erythropoiesis-stimulating agent (ESA). However, in individuals with CKD, iron treatment may lead to oversupplementation due to functional iron deficiency.
Hepcidin is a secreted protein mainly derived from the liver that plays a crucial role in the regulation of iron metabolism [3] . Specifically, hepcidin regulates iron efflux from intracellular iron by inducing the internalization and degradation of ferroportin (FPN), a cellular iron exporter [4] . Hepcidin levels are increased in patients with CKD [5] , as well as in experimental animal models of CKD [6, 7] . Increased hepcidin levels in patients with CKD may impair the proper use of stored iron and lead to FPN degradation, thereby contributing to functional iron deficiency and dysregulation of iron metabolism.
Indoxyl sulfate (IS) is a protein-bound uremic toxin and a metabolite of indole, a tryptophan metabolite that is synthesized by intestinal bacteria. In healthy subjects, IS is excreted in the urine via the renal proximal tubule; however, patients with impaired renal function show reduced excretion of IS, and it accumulates in their blood [8] . The accumulation of IS further predicts renal dysfunction in CKD [9] and high serum IS levels are associated with cardiovascular diseases and mortality in CKD patients [10] . IS also induces reactive oxygen species (ROS) as well as inflammation and exerts adverse effects on various organs [11] . AST-120, a sorbent of uremic toxin, has been shown to ameliorate CKD-related complications [12] [13] [14] [15] [16] [17] [18] [19] .
Regarding renal anemia in CKD, IS accumulation inhibits the hypoxia-inducible factor and thus reduces EPO production [20] . Furthermore, IS removal improves the effect of ESA on anemia in late-stage CKD patients [21] , indicating that IS mediates renal anemia via EPO regulation. However, it is not completely clear how IS accumulation impacts iron metabolism in CKD.
In the present study we evaluated the effect of IS on iron metabolism and found that IS augments hepatic hepcidin production. In a mouse model of adenine-induced CKD, mice with a high IS concentration showed increased hepatic and plasma hepcidin levels, decreased FPN expression in the duodenum and increased iron content in the spleen. These changes were ameliorated by AST-120 treatment. Our findings suggest that IS accumulation leads to increases in hepcidin, which in turn dysregulates iron metabolism in CKD.
M A T E R I A L S A N D M E T H O D S

Chemicals and reagents
IS potassium salt, adenine sulfate and AST-120 (Kremezin) were purchased from Sigma-Aldrich (St Louis, MO, USA), Wako Pure Chemical Industries (Osaka, Japan) and Kureha (Tokyo, Japan), respectively. N-acetyl cysteine (NAC), an antioxidant drug, and CH-223191, an inhibitor of aryl hydrocarbon receptor (AhR), were obtained from Sigma-Aldrich. The following commercially available antibodies were used for this study: anti-NRAMP2 (DMT1) antibody, anti-ferritin heavy chain (FTH), anti-ferritin light chain (FTL) and anti-AhR antibody (Santa Cruz Biotechnology, Santa Cruz, CA, USA); antitransferrin receptor 1 (TfR1) antibody (Zymed Technologies, Carlsbad, CA, USA); anti-FPN antibody (Alpha Diagnostics, San Antonio, TX, USA); anti-a-tubulin (Merck KGaA, Darmstadt, Germany), which was used as a protein loading control and antihistone H3 antibody (Abcam, Cambridge, UK), which was used as a loading control in the case of nuclear proteins.
Experimental animals and treatment
All experimental procedures involving animals were performed in accordance with the guidelines of the Animal Research Committee of Tokushima University Graduate School (permit number 13095). Eight-week-old male C57BL6/J mice were purchased from Nippon CLEA (Tokyo, Japan). The mice were maintained under conventional conditions, with a regular 12-h light/ dark cycle and free access to food (Type NMF; Oriental Yeast, Tokyo, Japan) and water during the study. Dietary adenine administration has been used to induce CKD in rodents [22] .
Animal experiment 1
We used a new protocol involving intraperitoneal adenine administration, as previously described [23] ; however, we modified the protocol of the previous study in that we administered 100 mg/kg of adenine three times per week for 4 weeks. One week after the start of adenine administration, serum creatinine was elevated by approximately 2-fold (vehicle versus adenine: 0.50 6 0.07 versus 0.87 6 0.15 mg/dL; P < 0.01). The mice that were receiving adenine were then divided into two groups and treated for three more weeks; specifically, a normal diet group and an AST-120 group, in which the normal diet was supplemented with 5% AST-120, were established [13, 19] . A control group received a normal diet, as well as intraperitoneal vehicle administration.
Animal experiment 2
To test the direct IS effect on hepcidin, 0.1% IS [200 mg (800 mmol)/kg/day] was administered to the mice in their drinking water for 2 weeks as previously described [19] . The mice were euthanized by intraperitoneal overdose injection of pentobarbital, their blood was collected and their tissue was removed and stored at À80 C until use.
Hematological analysis
Whole blood cell counts were performed by Shikoku Chuken (Kagawa, Japan) and serum creatinine levels were determined using an alkaline picrate-based assay (LabAssay Creatinine Kit, Wako Pure Chemical Industries).
Measurement of plasma iron levels, plasma ferritin levels and tissue iron concentration
Plasma iron levels and tissue iron concentrations were measured using an iron assay kit according to the manufacturer's instructions (Metallo Assay; Metallogenics, Chiba, Japan), as previously described [24] [25] [26] . Plasma ferritin levels were determined by a Mouse Ferritin ELISA Kit (Immunology Consultants Laboratory, Newberg, OR, USA) according to the manufacturer's instructions.
Cell culture
HepG2, a human hepatoma cell line, was purchased from the Japanese Collection of Research Bioresources (Osaka, Japan). The methods of cell culture have been previously described [26] . In some experiments the cells were pretreated for 1 h with either 100 mM tempol (ROS scavenger), 10 mM BAY11-7082 [nuclear factor jB (NF-jB) inhibitor], 100 mM NAC (antioxidant drug) or 10 mM CH-223191 (AhR inhibitor) before stimulation with IS. In other experiments, HepG2 cells were cultured in bovine serum albumin (BSA; 40 g/L) containing Dulbecco's modified Eagle's medium (DMEM) [11] . BSA was purchased from Wako Pure Chemical Industries and the concentration of endotoxin in the BSA solution was 0.03 ng/mL as detected using a Limulus Amebocyte Lysate assay (Pierce LAL Chromogenic Endotoxin Quantitation Kit; Thermo Fisher Scientific, Waltham, MA, USA).
RNA extraction and evaluation of mRNA expression levels
The RNA extraction, cDNA synthesis and quantitative reverse transcription polymerase chain reaction methods have Effect of indoxyl sulfate on hepcidin regulation been described previously [25] . 0 -GCTCCAAGCAGATGCAGCA-3 0 and 5 0 -CCGGATGT GAGGCAGCAG-3 0 for 36B4 as an internal control. The expression levels of all target genes were normalized using 36B4 and the values were compared with the control group in terms of relative fold changes.
Protein extraction and western blot analysis
Protein preparation was done and western blotting was performed as previously described [25] . Densitometry of the visualized bands was quantified using ImageJ 1.38x software. Protein staining by Ponceau S solution was used as a protein loading control in the duodenum.
Measurement of intracellular ROS levels
Intracellular ROS were detected using dichlorofluorescin diacetate (DCFH-DA; Sigma-Aldrich). HepG2 cells were stimulated, for various time periods using 250 mM IS, then they were incubated with 10 mM DCFH-DA at 37 C for 30 min. After washing, ROS production was quantified at 488 and 532 nm using a microplate reader (FilterMax F3 Multi-Mode Microplate Reader; Molecular Devices, Sunnyvale, CA, USA).
Small interfering RNA experiments
Small interfering RNA (siRNA) targeting human AhR and a nontargeting siRNA control sequence were commercially obtained from Sigma-Aldrich (Mission siRNA; Tokyo, Japan). Transfection was performed as previously described [26] . Briefly, subconfluent HepG2 cells were transfected for 24 h with 25 nM siRNA using the RNAiMAX V R reagent and OPTI-MEM (Life Technologies, Carlsbad, CA, USA). In all experiments, transfected HepG2 cells were used 48 h after transfection.
Measurement of IS and hepcidin concentrations in plasma and cell culture medium IS levels in mouse plasma were measured using highperformance liquid chromatography. The concentrations of human hepcidin-25 and mouse hepcidin-1 (same as mouse hepcidin-25) were quantitatively analyzed as previously described [27] . In brief, surface-enhanced laser desorption ionization time of flight mass spectrometry (MS) was used to analyze hepcidin-25. The molecular sizes of peptides at 2789 m/z matched with the reported sizes of hepcidin-25, and the serum peptide at 2789 m/z was identified as hepcidin-25 by collision-induced dissociation tandem MS. The assays were performed by Medical Care Proteomics Biotechnology (Kanazawa, Japan).
Evaluation of iron-regulatory protein and iron-responsive element binding activity
The interaction between iron-regulatory protein (IRP) and iron-responsive element (IRE) was evaluated using an electrophoretic mobility-shift assay kit (LightShift Chemilumi-nescent RNA EMSA Kit; Thermo Fisher Scientific, Rockford, IL, USA) as previously reported [24] . Semiquantification for IRP-IRE binding activity was performed using ImageJ 1.38x software.
Statistical analysis
Data are presented as mean 6 standard deviation (SD). An unpaired, two-tailed, Student's t-test was used for comparisons between the two groups. For comparisons between more than two groups, the statistical significance of each difference was evaluated using a post hoc test (either Dunnett's method or Tukey-Kramer's method). P-values < 0.05 indicated statistical significance.
R E S U L T S
Effect of IS on hepcidin expression in liver and cultured hepatic cell line IS stimulated hepcidin mRNA expression in a dosedependent manner in HepG2 cells ( Figure 1A) . Similarly, hepcidin secreted from HepG2 cells was increased by IS stimulation ( Figure 1B ). AhR is a receptor for IS, and activated AhR is translocated from the cytoplasm to the nucleus, where it promotes the transcription of target genes [28] . Indeed, IS stimulation promoted nuclear translocation of AhR in HepG2 cells at 30 min or later in the present study ( Figure 1C ). Therefore we used RNA interference to check whether AhR is involved in ISinduced hepcidin upregulation and observed that the siRNA reduced AhR mRNA levels to 27.0 6 3.0% of the control (P < 0.01) and reduced AhR protein levels to 38.9 6 16.7% of the control (P < 0.01). Silencing of AhR diminished IS-induced hepcidin expression ( Figure 1D ). Similarly, pharmacological AhR inhibition using CH-223191 suppressed IS-induced hepcidin expression ( Figure 1E ). These findings suggest that IS increases hepcidin expression via an AhR-mediated pathway.
Influence of albumin on IS-induced hepcidin expression
Uremic toxins such as IS exist as protein-bound toxins in the blood. Therefore we tested IS action on hepcidin in HepG2 cells cultured with BSA containing DMEM and confirmed that IS augmented hepcidin mRNA expression similarly in HepG2 cells cultured with DMEM with BSA as in those cultured with DMEM without BSA ( Figure 1F ). Moreover, there was no difference in basal hepcidin expression regardless of BSA inclusion.
Involvement of oxidative stress in IS-induced hepcidin expression
IS causes oxidative stress and the consequent activation of the NF-OEB pathway in endothelial cells and proximal tubular cells [29] [30] [31] . Similar to previous findings, IS caused oxidative stress in HepG2 cells in the present study ( Figure 2A ) and the IS-induced oxidative stress was suppressed by tempol, a superoxide scavenger ( Figure 2B ). IS-induced hepcidin upregulation was also suppressed by tempol, NAC or BAY11-7082, an inhibitor of NF-OEB ( Figure 2C -E). With regard to the relationship between oxidative stress and the AhR pathway, tempol failed to block IS-induced translocation of AhR to the nucleus from the cytoplasm ( Figure 2F ). Conversely, AhR knockdown did not prevent IS-mediated oxidative stress in HepG2 cells ( Figure  2G ). Moreover, concomitant treatment with AhR siRNA and BAY-11-7082 almost blocked IS-induced hepcidin expression ( Figure 2H ). These results suggest that IS-induced hepcidin expression is also mediated via the oxidative stress-NF-OEB pathway and that it is independent of the AhR pathway.
Changes in hepcidin levels in adenine-induced CKD mice
To assess iron metabolism in CKD, we used mice with adenine-induced CKD. In adenine-induced CKD mice, hepatic hepcidin expression and plasma hepcidin concentration were significantly increased 4 weeks after the start of adenine administration ( Figure 3A and B). These increases in both hepatic hepcidin expression and plasma hepcidin concentration were diminished by AST-120 treatment. As shown in Figure 3D , hepcidin concentration was positively correlated with IS levels, suggesting that IS is closely associated with hepcidin levels. These results indicate that IS accumulation involves hepcidin regulation in CKD mice.
Alterations in tissue iron content in adenine-induced CKD mice
We examined the impact of IS accumulation on the tissue iron content in adenine-induced CKD mice. As shown in Table 1 , iron content was elevated in the spleen and skeletal muscle in adenine-induced CKD mice and these increases in Effect of indoxyl sulfate on hepcidin regulation iron content were subsequently decreased by AST-120 treatment. Duodenal iron content was also increased in adenineinduced CKD mice, but it was not changed by AST-120 treatment. In contrast, while CKD mice presented with decreased iron content in the liver and kidney, AST-120 did not ameliorate this effect. The findings of decreased plasma iron levels and increased plasma ferritin levels in the adenine-induced CKD mice are compatible with functional iron deficiency and both the iron and ferritin levels in the blood were ameliorated by AST-120 treatment. These results indicate impaired iron distribution and utilization in CKD mice.
FPN expression in the duodenum and spleen
As described above, hepcidin regulates cellular iron efflux via the internalization and degradation of FPN; hepcidin upregulation in CKD mice might therefore reduce the expression of FPN. As expected, FPN expression was diminished in the duodenum of CKD mice ( Figure 4A ) and its expression levels were restored by AST-120 treatment. In contrast, splenic FPN expression was augmented in CKD mice, and this change was also reversed by AST-120 ( Figure 5A ). In the spleens of CKD mice, FPN mRNA expression was increased and IRP-IRE binding activity was reduced, which was consistent with increased FPN protein expression. The changes in FPN mRNA and IRP activity were also improved by AST-120 treatment, which corresponded with the reduction of FPN expression ( Figure 5G and H). IRP-IRE binding activity was regulated by iron content and the change in IRP activity corresponded with changes in splenic iron content. These findings suggest that FPN is posttranscriptionally regulated, independent of hepcidin, in the spleens of CKD mice.
Protein expression of iron importers and iron storage in the duodenum and spleen Next, we examined the protein expression of iron importers and iron storage in the duodenum and spleen. In the duodenum, the expression levels of DMT1, FTH and FTL did not differ among the three groups ( Figure 4B-D) . Although no difference in DMT1 expression was seen, levels of TfR were decreased, and those of FTH and FTL were elevated in the spleens of CKD mice. These changes were all reversed by AST-120 treatment ( Figure 5B-E) . Moreover, splenic hepcidin expression was significantly reduced in adenine-induced CKD mice, which tended to be restored by AST-120 treatment ( Figure 5F ).
Effect of IS removal on anemia in adenine-induced CKD mice
Adenine-induced CKD mice demonstrated microcytic hypochromic anemia after 4 weeks of adenine treatment (Table  2) . Treatment using AST-120 improved impaired iron absorption and utilization in adenine-induced CKD mice and renal anemia was partly prevented by AST-120 treatment. CKDinduced elevation of plasma creatinine was slightly suppressed by AST-120 at 4 weeks (Table 3 ) and renal EPO expression remained at low levels in CKD mice despite AST-120 treatment ( Figure 6 ). In addition, there were no differences in plasma creatinine and the degree of anemia between the adenine-induced CKD mice and the adenine-induced CKD mice treated with AST-120 after 2 weeks of adenine treatment and 1 week of AST-120 treatment (Tables 2 and 3 ). These data suggest that AST-120 restored iron incorporation and utilization by suppressing a pathway that is hepcidin/FPN dependent and EPO independent. Data are presented as mean 6 SD; n ¼ 3-14. *P < 0.05, **P < 0.01 versus control mice. # P < 0.05, ##P < 0.01 versus adenine diet.
Effect of indoxyl sulfate on hepcidin regulation
Changes in mRNA expression of the inflammatory cytokines
Interleukin-6 (IL-6) plays an important role in hepcidin regulation [32] . We examined the participation of inflammatory cytokines in hepcidin expression in adenine-induced CKD mice. As shown in Figure 7 , the mRNA expression of IL-6, as well as TNF-a and tumor necrosis factor a (IL-1b), was increased in the kidneys of adenine-induced CKD mice. In contrast, the mRNA expression of those genes was decreased in the livers of adenine-induced CKD mice, indicating a lack of involvement of inflammatory cytokines in hepcidin regulation in the livers of adenine-induced CKD mice.
Direct effect of IS on hepcidin in mice with IS treatment
We examined whether IS has a direct effect on hepatic hepcidin expression using mice that had been administered IS. IS treatment augmented hepatic hepcidin mRNA expression as well as plasma hepcidin concentration ( Figure 8A and B) . IS administration also induced mild anemia despite no difference in plasma creatinine levels between the control mice and those that were administered IS ( Figure 8C and Table 4 ). Therefore, IS directly affects hepcidin regulation independent of renal function.
D I S C U S S I O N
In the in vitro experiments of the present study, IS augmented hepatic hepcidin expression via a pathway that depended on both AhR and oxidative stress. Similarly, hepatic and plasma hepcidin levels were increased in the in vivo experiments using adenine-induced CKD mice. The CKD mice also showed decreased FPN expression in the duodenum and increased splenic iron concentrations. The alterations in iron metabolism in the CKD mice were ameliorated by AST-120, which removes IS. These observations suggest, for the first time, the involvement of IS in iron metabolism in CKD.
Hepcidin was first identified as an antimicrobial peptide that plays an important role in the regulation of iron metabolism [3] . Specifically, hepcidin regulates cellular iron efflux via both the internalization and degradation of FPN [4] . Therefore CKD-related increases in hepcidin levels contribute to the intracellular sequestration of iron, as well as impaired absorption of iron from the duodenum, and such changes promote functional iron deficiency in CKD. Indeed, several studies have shown that the serum hepcidin concentration is elevated in CKD, which contributes to whole-body iron dysregulation. Moreover, elevated serum hepcidin levels are correlated with serum ferritin levels and inflammatory markers in patients with CKD [5] . Adenine-induced CKD animals show increases in hepatic hepcidin as well as abnormal iron metabolism [6, 7] . In the present study we found that hepatic hepcidin expression and plasma hepcidin concentration were elevated in adenine-induced CKD mice. These hepcidin increases were rectified by the removal of IS. The present study is the first to reveal the association between IS and hepcidin regulation.
To investigate the mechanism by which IS regulates hepcidin concentrations, we used HepG2 cells and found that IS also increased hepcidin expression in these cells. Previously, Schroeder et al. [28] demonstrated that IS is a ligand of AhR and that IS acts via AhR. In the current investigation, IS promoted the translocation of AhR to the nucleus from the cytoplasma in HepG2 cells and the IS-induced hepcidin upregulation was reversed by AhR silencing. Similarly, previous Effect of indoxyl sulfate on hepcidin regulation studies have shown that various IS actions are prevented by AhR silencing [33] . Taken together, clearly the effect of IS on hepcidin is exerted through an AhR-mediated pathway. IS is known to cause oxidative stress, consequently the toxin activates NF-jB signaling [29] [30] [31] 34] . In the present study, IS-induced hepcidin augmentation was suppressed by both a free radical scavenger and an NF-jB inhibitor, suggesting that the IS-induced oxidative stress-NF-jB axis is involved in hepcidin regulation. However, IS-induced oxidative stress was not reduced by AhR siRNA and tempol did not inhibit the IS-induced translocation of AhR to the nucleus. In addition, IS-induced hepcidin upregulation was almost completely abolished by the simultaneous inhibition of the AhR and NF-jB pathways. These results suggest that IS/oxidative stress-induced (/mL) 5200 6 2100 3700 6 700 3700 6 1300 4300 6 1800 4600 6 2600 5200 6 3200 2600 6 1100** 2900 6 1200* Plt count (Â 10 4 /mL) 51. Data are presented as mean 6 SD; n ¼ 3-15. *P < 0.05, **P < 0.01 versus control mice at the same week. # P < 0.05 ##P < 0.01 versus adenine diet at the same week. RBC, red blood cell; Hb, hemoglobin; Ht, hematocrit; MCV, mean corpuscular volume; MCH, mean corpuscular hemoglobin; MCHC, mean corpuscular hemoglobin concentration; WBC, white blood cell; Plt, platelet. Table 3 . Characteristics of the control mice and adenine-CKD mice with or without AST-120 treatment hepcidin expression occurs independently of any AhRmediated pathway.
In contrast to our results, several studies have shown that hepcidin is downregulated by oxidative stress induced by alcohol [35] or the hepatitis C virus [36] . However, pathophysiologically relevant hydrogen peroxide levels have been shown to upregulate hepcidin expression via STAT3 [37] . In terms of the effect of NF-jB on hepcidin, a previous study showed that lipopolysaccharide-induced hepcidin upregulation is mediated by NF-jB dependency, which is similar to our finding [38] . In contrast, ceramide-induced hepcidin regulation is not involved in the NF-jB pathway [39] . Therefore, oxidative stress and NF-jB have dual characteristics as either positive or negative regulators of hepcidin.
Uremic solutes normally exist as protein-bound toxins and several studies, including the present study, used high concentrations of IS relative to the concentrations in uremic CKD patients in the in vitro experiments [11, 40] . Therefore we tested the IS effect on hepcidin in HepG2 cells by using both the free concentration (25 mM) in albumin-free DMEM and the protein-bound maximum concentration (250 mM) in DMEM containing BSA. A total of 25 mM of IS induced an approximately 2-fold increase in hepcidin mRNA expression in HepG2 cultured with BSA-free DMEM and 250 mM IS also increased hepcidin mRNA expression in HepG2 cultured with BSAcontaining DMEM. In addition, there was no difference in basal hepcidin mRNA expression in DMEM regardless of BSA inclusion, indicating no impact of albumin on hepcidin expression ( Figure 1F ). Thus hepcidin expression was upregulated by IS at the free concentration and protein-bound concentration doses in HepG2 cells under our experimental condition.
Inflammatory cytokines (i.e. IL-6) are also important factors in hepcidin regulation [32] . As expected, the expression of IL-6, IL-1b and TNF-a mRNA was upregulated in the kidney in CKD mice. However, it was decreased in the liver. Although the reason for the discrepancy in inflammatory cytokine expression between the kidney and liver remains unclear, inflammatory cytokines might not be associated with the regulation of hepatic hepcidin in an adenine-induced CKD mouse model.
Regarding alterations in iron distribution in CKD mice, iron concentrations in the spleen, duodenum and skeletal muscle were increased. Plasma ferritin was also increased, though plasma iron was decreased, indicating that iron absorption and utilization were impaired. These alterations were mostly ameliorated by AST-120 treatment. It follows that IS removal, and the resulting inhibition of hepcidin, might improve iron metabolism and iron utilization in CKD. Consistent with this result, decreased expression of FPN in the duodenum was restored by AST-120 treatment in CKD mice, indicating that IS removal affects hepcidin levels. Conversely, CKD mice showed increased FPN expression in the spleen, which was reduced by AST-120 treatment. It is not clear why the discrepancy of increased FPN expression in the spleen combined with elevated hepcidin in the liver and serum is present in CKD mice. FPN expression is controlled by both transcriptional and post-transcriptional regulation, as well as by the translational regulation of hepcidindependent internalization. In macrophages, FPN transcription is induced by iron as well as by heme protein [41] . Additionally, FPN mRNA has an IRE in the 5 0 -region [42] and its translation is therefore increased by high iron levels because it can bind to IRP1 [43] . In the spleens of CKD mice, FPN mRNA was increased and IRP activity was reduced, which is consistent Data are presented as mean 6 SD; n ¼ 4. *P < 0.05, **P < 0.01 versus vehicle mice. RBC, red blood cell; Hb, hemoglobin; Ht, hematocrit; MCV, mean corpuscular volume; MCH, mean corpuscular hemoglobin; MCHC, mean corpuscular hemoglobin concentration; WBC, white blood cell; Plt, platelet.
with the understanding that increased FPN protein expression is responsible for the transcriptional upregulation. Therefore we suggest that the increased FPN expression seen in CKD mice is likely responsible for the accumulation of iron in the spleen and that this accumulation overwhelms hepcidinmediated mechanisms. In addition, hepcidin expression has been observed in not only the liver, but also in the heart [44] , kidney [45] , brain [46] and spleen [47] . Although the function of extrahepatic hepcidin remains unknown, it might influence local iron regulation. In the present study, hepcidin expression was reduced in the spleens of adenine-induced CKD mice, indicating the involvement of local hepcidin on the regulation of splenic FPN expression. Further examination is necessary to clarify whether there is a coordinated regulation of peripheral FPN expression or hepatic hepcidin levels. CKD mice showed renal anemia compatible with irondeficient anemia, which is caused by iron sequestration and impaired iron utilization as well as by reduced renal EPO production. The renal anemia was slightly improved by AST-120 treatment, perhaps because consequent reductions in hepcidin restored iron utilization. In previous studies, hepcidin inhibition ameliorated erythropoiesis in a model of CKD combined with renal anemia, hepcidin-deficient mice and mice that had been treated with a hepcidin inhibitor [7, 48] . This suggests that hepcidin inhibition mobilizes iron and improves iron utilization. In the same way, the removal of IS using AST-120 ameliorated iron accumulation in the spleen and skeletal muscle as well as elevated plasma ferritin levels. Conversely, the treatment reduced plasma iron levels in CKD mice, indicating that iron mobilization in tissues with ectopic iron accumulation had been improved. Moreover, AST-120 slowed the progression of renal dysfunction as estimated by plasma creatinine level; however, the decrease of renal EPO expression in CKD mice was not changed by IS removal. Therefore IS removal ameliorates renal anemia via the restoration of iron utilization rather than through increased EPO production. Additionally, cyanate, formed spontaneously from accumulated urea, decreases EPO activity in order to induce EPO carbamylation [49, 50] , which might promote inadequate erythropoiesis in CKD.
A recent clinical study [Evaluating Prevention of Progression in CKD (EPPIC)] demonstrated that AST-120 fails to prevent disease progression in patients with moderate to severe CKD [51] . Moreover, a subgroup analysis within the EPPIC study revealed that AST-120 delays the primary endpoint (dialysis initiation, kidney transplantation or serum creatinine doubling) in American patients [52] . Thus it remains controversial whether IS removal prevents renal dysfunction in CKD. Nonetheless, the uremic toxicity of IS accumulation causes dysfunction in various organs through multiple pathways. Further examination is necessary to elucidate the effect of AST-120 on renal anemia in CKD.
In conclusion, IS induces hepcidin production via a pathway that involves both AhR and oxidative stress. This results in iron sequestration and impaired iron utilization in CKD. AST-120 ameliorates iron metabolism by inhibiting hepcidin increases, promoting iron mobilization and ameliorating erythropoiesis. These findings suggest that a therapeutic strategy of uremic toxin removal may be useful for correcting impaired iron metabolism in CKD. 
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